Tirzepatide (40mg)

$100.00

1 Unit
$100 per unit
$100.00
2 Units
$97.5 per unit (save 3% per unit)
$195.00
$200.00
3 Units
$95 per unit (save 5% per unit)
$285.00
$300.00
4 Units
$92.5 per unit (save 8% per unit)
$370.00
$400.00
5 Units
$90 per unit (save 10% per unit)
$450.00
$500.00
6 Units
$87.5 per unit (save 13% per unit)
$525.00
$600.00
7 Units
$85 per unit (save 15% per unit)
$595.00
$700.00
8 Units
$82.5 per unit (save 18% per unit)
$660.00
$800.00
9 Units
$80 per unit (save 20% per unit)
$720.00
$900.00
10 Units
$77.5 per unit (save 23% per unit)
$775.00
$1,000.00
Category:

Description

Tirzepatide is a dual-action peptide therapy that activates both GLP-1 and GIP receptors, offering significant benefits for blood sugar control and weight management in individuals with type 2 diabetes and obesity.
Clinical trials have demonstrated its ability to reduce HbA1c levels by up to 2.3% and achieve substantial weight loss, with some patients losing over 12 kg.

Improved Glycemic Control: Tirzepatide enhances insulin secretion and reduces glucagon release, leading to better regulation of blood glucose levels.
Significant Weight Loss: It promotes weight reduction by suppressing appetite, increasing satiety, and slowing gastric emptying, with clinical trials showing up to 20% body weight loss in some cases.
Enhanced Insulin Sensitivity: The peptide improves the body’s response to insulin, which is particularly beneficial for individuals with insulin resistance.
Cardiovascular Risk Reduction: Evidence suggests tirzepatide may lower cardiovascular risks, although further research is ongoing.
Convenient Dosing: Administered as a once-weekly subcutaneous injection, it offers a convenient regimen compared to daily medications.
Lower Hypoglycemia Risk: Due to its glucose-dependent mechanism, tirzepatide carries a reduced risk of causing low blood sugar compared to some other diabetes treatments.
Additional Metabolic Benefits: It may improve lipid metabolism and energy balance, contributing to overall metabolic health